Litcius/Paper detail

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial

Michael G. Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, Melissa Mitchener, Kenji J. Tsuchiya, Takeki Uehara, Frederick G. Hayden

2020The Lancet Infectious Diseases264 citationsDOI

Topics & Concepts

OseltamivirMedicinePlaceboInternal medicinePopulationClinical endpointRandomized controlled trialPediatricsDiseasePathologyAlternative medicineCoronavirus disease 2019 (COVID-19)Environmental healthInfectious disease (medical specialty)Influenza Virus Research StudiesRespiratory viral infections researchSmoking Behavior and Cessation
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial | Litcius